Vimarsana
Biggest News Aggregation in the World

Page 3 - Michaelf Murphy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michaelf Murphy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michaelf Murphy Today - Breaking & Trending Today

05.26.21 -- How Takeda Is Expanding Its Real-World Data Through A Global Myeloma Trial - Vimarsana News

05.26.21 -- How Takeda Is Expanding Its Real-World Data Through A Global Myeloma Trial

05.26.21 -- How Takeda Is Expanding Its Real-World Data Through A Global Myeloma Trial     Combining drugs that may have been shelved with established, safe, and approved drugs has the potential to bring safer, effective therapies to patients. Attend this webinar to learn more about key trends, understanding technical challenges, and shortening timelines by smart working in parallel for scale-up and late-phase development. Click here to register. Featured Editorial By Dawn Marie Stull, Takeda Oncology There is more focus than ever before on tailoring treatm...

05.24.21 -- Eli Lilly Weighs The Benefits & Challenges Of Head-To-Head Trials - Vimarsana News

05.24.21 -- Eli Lilly Weighs The Benefits & Challenges Of Head-To-Head Trials

05.24.21 -- Eli Lilly Weighs The Benefits & Challenges Of Head-To-Head Trials     This report provides data on 240 service provider encounters with 18 electronic clinical outcome assessment/electronic patient reported outcomes (eCOA/ePRO) systems. eCOA/ePRO providers: Learn how your company performs against competitors. Discover where performance exceeds expectations so you can differentiate your offerings from competitors. For sponsors/CROs: Compare your company’s outsourcing philosophy to that of the broader industry. Evaluate your provider selection pr...

02.10.21 -- AI And Machine Learning Prepare Pharma For The Data Onslaught - Vimarsana News

02.10.21 -- AI And Machine Learning Prepare Pharma For The Data Onslaught

02.10.21 -- AI And Machine Learning Prepare Pharma For The Data Onslaught     With the spread of SARS-CoV-2 (COVID-19) intensifying, scientists, together with pharmaceutical companies, are reinventing the approach of how to bring life-saving drugs to market. Attend this webinar to learn more about bringing life-saving drugs to market faster without impacting product quality, safety, or efficacy and the impacts and comparisons of classic platforms vs. new-generation platforms. And more!   By Ed Miseta, chief editor, Clinical Leader When I reached out to sev...

ALS Studies And Lessons Learned From COVID-19 - Vimarsana News

ALS Studies And Lessons Learned From COVID-19

For ALS trial sponsors and CROs alike, the need to protect the health of study participants, the study team, on-site health care professionals, and...

12.21.20 -- Lilly, Care Access Take COVID Trial Directly To Patients - Vimarsana News

12.21.20 -- Lilly, Care Access Take COVID Trial Directly To Patients

12.21.20 -- Lilly, Care Access Take COVID Trial Directly To Patients     Introducing WCG IRB — We’re combining best-in-class capabilities to raise the bar for our industry. Building on our 52-year legacy of expertise and service, our five industry-leading IRBs are now WCG IRB — one unified team protecting human research participants and delivering a seamless review experience. Together at the forefront of research we are reshaping the future of ethical review with our unified experience and revolutionary new submission platform. Empowering research an...